Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

BVMF/JNJB34 stock hub

BVMF/JNJB34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVMF/JNJB34is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.6T

Brazil Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVMF/JNJB34

In the news

Latest news · BVMF/JNJB34

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.6

P25 11.3P50 14.6P75 19.6

Trailing P/E23.7

P25 15.2P50 21.5P75 27.3

ROE26.4

P25 5.3P50 12.3P75 22.5

ROIC19.9

P25 7P50 12.5P75 22.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVMF/JNJB34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	BR
Employees	138,200
Employees Change	6,200%
Employees Change Percent	4.7
Enterprise value	BRL 2.8T
Exchange	Brazil Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Last refreshed	2026-05-10
Market cap	BRL 2.6T
Price	BRL 72.55
Price currency	BRL
Rev Per Employee	3,654,344.07x
Sector	Healthcare
Sic	2834
Symbol	bvmf/JNJB34
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.23%
EV Earnings	25.13x
EV/EBIT	21.27x
EV/EBITDA	16.39x
EV/FCF	29.73x
EV/Sales	5.87x
FCF yield	3.57%
Forward P/E	18.56x
P/B ratio	6.13x
P/E ratio	23.66x
P/S ratio	5.17x
PE Ratio10 Y	45.82x
PE Ratio3 Y	18.63x
PE Ratio5 Y	21.16x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.59%
EBITDA Margin	35.62%
FCF margin	18.46%
Gross margin	68.04%
Gross Profit	BRL 343.6B
Gross Profit Growth	6.69%
Gross Profit Growth Q	9.85%
Gross Profit Growth3 Y	6.7%
Gross Profit Growth5 Y	3.28%
Net Income	BRL 110.3B
Net Income Growth	-3.53%
Net Income Growth Q	-52.41%
Net Income Growth3 Y	18.25%
Net Income Growth5 Y	6.84%
Pretax Margin	25.88%
Profit Margin	21.83%
Profit Per Employee	BRL 797,902
ROA	8.42
Roa5y	8.04
ROCE	18.57
ROE	26.42
Roe5y	24.21
ROIC	19.95
Roic5y	23.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	12.76%
Cagr1y	22.87%
Cagr3y	12.92%
Cagr5y	6.2%
Div CAGR10	10.09%
Div CAGR3	6.72%
Div CAGR5	6.01%
EPS Growth	-3.89
EPS Growth Q	-52.86
EPS Growth3 Y	21.64
EPS Growth5 Y	8.81
FCF Growth	-12.7%
FCF Growth Q	-56.64%
FCF Growth3 Y	3.14%
FCF Growth5 Y	-3.13%
OCF Growth	-7.72%
OCF Growth Q	-39.77%
OCF Growth10 Y	1.93%
OCF Growth3 Y	3.76%
OCF Growth5 Y	-1.17%
Revenue Growth	7.87x
Revenue Growth Q	9.91x
Revenue Growth3 Y	7.55x
Revenue Growth5 Y	2.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	BRL 0.49
Assets	BRL 1.1T
Cash	BRL 115.6B
Current Assets	BRL 290.8B
Current Liabilities	BRL 283.6B
Debt	BRL 288.2B
Debt EBITDA	BRL 1.59
Debt Equity	BRL 0.68
Debt FCF	BRL 3.09
Equity	BRL 425.5B
Interest Coverage	25.59
Liabilities	BRL 627.4B
Long Term Assets	BRL 762.1B
Long Term Liabilities	BRL 343.8B
Net Cash	BRL -172.6B
Net Cash By Market Cap	BRL -6.62
Net Debt EBITDA	BRL 0.96
Net Debt Equity	BRL 0.41
Net Debt FCF	BRL 1.85
Tangible Book Value	BRL -86.1B
Tangible Book Value Per Share	BRL -35.79
WACC	5.29

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Inventory Turnover	2.26
Net Working Capital	BRL -16.4B
Quick ratio	0.69
Working Capital	BRL 7.6B
Working Capital Turnover	BRL 62.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.29%
Dividend Growth	-0.27%
Dividend Growth Years	8%
Dividend per share	BRL 1.24
Dividend Years	16
Dividend Yield	1.71%
Ex Div Date	2026-02-24
Last Dividend	BRL 0.3
Payout Frequency	Quarterly
Payout Ratio	59.52%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	232.34%
1Y total return	22.85%
200-day SMA	72.89
3Y total return	43.99%
50-day SMA	80.78
50-day SMA vs 200-day SMA	50over200
5Y total return	35.09%
All Time High	87.77
All Time High Change	-17.34%
All Time High Date	2026-03-03
All Time Low	7.11
All Time Low Change	920.11%
All Time Low Date	2012-09-04
ATR	1.73
Beta	0.26
Ch YTD	-4.12
High	73.33
High52	87.77
High52 Date	2026-03-03
High52ch	-17.34%
Low	72.18
Low52	54.62
Low52 Date	2025-05-14
Low52ch	32.83%
Ma50ch	-10.19%
Price vs 200-day SMA	-0.47%
RSI	28.32
RSI Monthly	56.85
RSI Weekly	42.16
Sharpe ratio	1.04x
Sortino ratio	1.93
Total Return	1.42%
Tr YTD	-3.77
Tr1m	-11.25%
Tr1w	-2.68%
Tr3m	-12.63%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	BRL 139.4B
Operating Income Growth	17.5
Operating Income Growth Q	4.05
Operating Income Growth3 Y	6.76
Operating Income Growth5 Y	4.61
Operating margin	27.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,403,389,742%
Net Borrowing	8,845,560,000
Shares Insiders	0.04%
Shares Institutions	75.42%
Shares Qo Q	0.25%
Shares Yo Y	0.29%
Short Ratio	2.44

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	BRL 86B
Average Volume	9,519.45x
Bv Per Share	176.8
CAPEX	BRL -26.7B
Ch10y	177.3
Ch1m	-11.25
Ch1w	-2.68
Ch1y	20.62
Ch3m	-12.96
Ch3y	35.61
Ch5y	23.03
Ch6m	9.94
Change	-0.14%
Change From Open	-1.06
Close	72.65
Days Gap	0.94
Depreciation Amortization	38,011,337,000
Dollar Volume	6,877,377.3
Earnings Date	2026-04-14
EBIT	BRL 139.4B
EBITDA	BRL 179.9B
EPS	BRL 45.26
F Score	5
FCF	BRL 93.2B
FCF EV Yield	3.36x
Financing CF	-80,873,408,070
Fiscal Year End	December
Founded	1,886
Goodwill	238,623,723,600
Graham Number	28.56831
Graham Upside	-60.62
Income Tax	BRL 20.4B
Investing CF	-127,518,041,070
Is Primary Listing	0
Last Earnings Date	2026-04-14
Last Report Date	2026-03-29
Last Split Date	2021-01-27
Last Split Type	Forward
Lynch Fair Value	BRL 20.97
Lynch Upside	-71.1
Ma150	76.17
Ma150ch	-4.75%
Ma20	76.41
Ma20ch	-5.05%
Net CF	-87,974,922,420
Next Earnings Date	2026-07-14
Open	73.33
P FCF Ratio	27.99
P OCF Ratio	21.77
Payment Date	2026-03-19
Position In Range	32.17
Ppne	114,353,434,000
Price Date	2026-05-08
Price EBITDA	BRL 14.5
Relative Volume	9.96x
Revenue	505,030,351,140x
SBC By Revenue	1.42x
Share Based Comp	7,159,165,020
Tax By Revenue	4.05x
Tax Rate	15.64%
Tr6m	10.82%
Volume	94,795
Z Score	4.38

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVMF/JNJB34 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$1.24 annual per share

Payout ratio

+59.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+6.0%

8 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2026-02-24

Performance

BVMF/JNJB34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVMF/JNJB34?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.4%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVMF/JNJB34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.3

Below 30: short-term oversold

Price vs 200-day MA

-0.5%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

1.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVMF/JNJB34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/JNJB34 stock rating?

bvmf/JNJB34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/JNJB34 analysis?

The full report lives at /stocks/bvmf/JNJB34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/JNJB34?

The latest report frames bvmf/JNJB34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/JNJB34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.